Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 68Active not recruiting 16Terminated 12Unknown 5Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 3Sarcoma 2Genitourinary 1

Conditions

Ovarian Neoplasms 2Sarcoma, Alveolar Soft Part 1Sarcoma 1Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinosarcoma 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × cediranib × Clear all
NCT03741426 2023-06-07

WIRE

Cambridge University Hospitals NHS Foundation Trust

Phase 2 Unknown
60 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT03278717 2022-09-27

ICON9

University College, London

Phase 3 Unknown
330 enrolled
Gynecologic

Ovarian Neoplasms

NCT03570437 2022-03-02

COPELIA

University of Manchester

Phase 2 Unknown
124 enrolled
GynecologicSarcoma

Carcinosarcoma, Neoplasms, Endometrial Neoplasms

NCT01337401 2019-01-24

CASPS

Institute of Cancer Research, United Kingdom

Phase 2 Unknown
36 enrolled
Sarcoma

Sarcoma, Sarcoma, Alveolar Soft Part

NCT00532194 2015-09-23

ICON6

Medical Research Council

Phase 3 Unknown
486 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡